Training in the Fasted State, Glucose Metabolism and Energy Balance
- Conditions
- Glucose Metabolism Disorders
- Interventions
- Behavioral: ExerciseBehavioral: Maintain habitual habitsBehavioral: Breakfast
- Registration Number
- NCT02744183
- Lead Sponsor
- University of Bath
- Brief Summary
In healthy individuals, the body responds to glucose (sugar) ingestion by reducing the amount released from the liver. At the same time, skeletal muscles increase the rate at which they remove the glucose from the bloodstream, via the actions of the hormone insulin. This ensures that blood glucose levels remain in a controlled range. However, in developed countries, diseases such as metabolic syndrome and type 2 diabetes are becoming prevalent, due to dietary modifications and a reduction in physical activity. As one of the prominent barriers to regular physical activity is a lack of time, finding ways to maximize the health benefits of exercise is a priority for researchers.
The investigators want to understand potential differences in the effects of six weeks of aerobic training, with the exercise performed either after breakfast or after a prolonged fast. Specifically, this research aims to investigate whether there is a difference in the change in processes implicated in glucose regulation and secondly, in subsequent eating and physical activity behaviors. By investigating these changes this work will explore how exercise and nutrition can be optimized to benefit health and weight loss.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 30
- Male
- Aged 18-49
- Body mass index (BMI) > 25 kg/m2
- Weight stable for > 6 months
- Not currently engaging in any form of structured exercise
- Be able and willing to give informed oral and written consent
- Complete and meet the defined criteria of pre-study questionnaires and screen
- Have a history of metabolic, cardio-pulmonary or musculoskeletal disease
- Have plans to change diet and/or physical activity outside of the intervention
- Taking regular medication or food supplements from which it is not possible to refrain and which are known to influence any of the outcome measures.
- Failure to refrain from alcohol and/or caffeine containing drinks or strenuous exercise one day before or during the trial days
- Smokers
- Any reported condition or behavior deemed to pose a risk to the participant or introduce bias into the experiment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fasted Exercise Exercise 6 weeks of moderate intensity exercise with breakfast omission Fed Exercise Breakfast 6 weeks of moderate intensity exercise with breakfast consumption Control Group Maintain habitual habits Maintain habitual habits Fed Exercise Exercise 6 weeks of moderate intensity exercise with breakfast consumption
- Primary Outcome Measures
Name Time Method Postprandial plasma glucose concentrations 120 mins - (change after 6 weeks) Response to oral glucose tolerance test (area under the curve)
Postprandial insulin concentrations 120 mins - (change after 6 weeks) Response to oral glucose tolerance test (area under the curve)
- Secondary Outcome Measures
Name Time Method Oral Glucose Insulin Sensitivity Index 120 mins - (change after 6 weeks) Response to oral glucose tolerance test
Habitual energy expenditure Change after 6 weeks Assessed via an Actiheart monitor, completed at baseline and during the last week of the intervention
Waist and hip circumference (cm) Change after 6 weeks Cardiorespiratory fitness (VO2max) Change after 6 weeks Habitual energy intake Change after 6 weeks Assessed via a food diary, completed at baseline and during the last week of the intervention
Body mass (kg) Change after 6 weeks Fasting plasma glucose concentration Basal Concentrations - (change after 6 weeks) Fasting plasma glucose concentration (mmol/L)
Maximal rate of whole-body lipid oxidation (g/min) Change after 6 weeks During an incremental exercise test
Fasting plasma HDL cholesterol concentrations Basal Concentrations - (change after 6 weeks) Fasting plasma HDL cholesterol concentrations (mmol/L)
Fasting plasma LDL cholesterol concentrations Basal Concentrations - (change after 6 weeks) Fasting plasma LDL cholesterol concentrations (mmol/L)
Postprandial plasma glycerol concentrations Change after 6 weeks Response to oral glucose tolerance test (total and incremental area under the curve)
Fasting plasma insulin concentration Basal Concentrations - (change after 6 weeks) Fasting plasma insulin concentration (pmol/L)
Postprandial non-esterified fatty acid concentrations 120 mins - (change after 6 weeks) Response to oral glucose tolerance test (total and incremental area under the curve)
Citrate Synthase Activity (mitochondrial citrate synthase activity in each muscle sample in an immunocapture based manner) Change after 6 weeks Skeletal muscle (vastus lateralis). Citrate Synthase Activity Assay Kit.
Fasting plasma triglyceride concentrations Basal Concentrations - (change after 6 weeks) Fasting plasma triglyceride concentrations (mmol/L)
Fasting plasma total cholesterol concentrations Basal Concentrations - (change after 6 weeks) Fasting plasma total cholesterol concentrations (mmol/L)
Fasting plasma non-esterified fatty acid concentrations Basal Concentrations - (change after 6 weeks) Fasting plasma non-esterified fatty acid concentrations (mmol/L)
Waist to hip ratio Change after 6 weeks Waist circumference (cm) divided by hip circumference (cm)
Protein content of mitochondrial respiratory chain proteins Change after 6 weeks. For each participant the protein content will be presented as the fold change from baseline (arbitrary units). Skeletal muscle (vastus lateralis). Complex I, Complex II, Complex III, Complex IV.
Resting metabolic rate (RMR) Change after 6 weeks Assessed via indirect calirometry
Adipose Tissue Insulin Resistance Index (Adipo-IR) Change after 6 weeks Response to oral glucose tolerance test (total and incremental area under the curve)
Protein content of carnitine palmitoyltransferase I (CPT-1) Change after 6 weeks. For each participant the protein content will be presented as the fold change from baseline (arbitrary units) Skeletal muscle (vastus lateralis)
Protein content of cluster of differentiation 36 (CD36) Change after 6 weeks. For each participant the protein content will be presented as the fold change from baseline (arbitrary units) Skeletal muscle (vastus lateralis)
Protein content (total and phosphorylated form) of AMP-activated protein kinase (AMPK) Change after 6 weeks. For each participant the protein content will be presented as the fold change from baseline (arbitrary units) Skeletal muscle (vastus lateralis)
Whole-body carbohydrate utilisation during exercise Change throughout complete training period (weeks 1 through to 6). Samples will be collected during every training session (three times weekly for six weeks) Assessed via indirect calirometry during every exercise session (at ten minute intervals)
Homeostasis Model Assessment (HOMA2-IR) Change after 6 weeks The Homeostasis Model Assessment (HOMA) estimate of steady state beta cell function (%B) and insulin sensitivity (%S). Derived from fasting plasma glucose and fasting plasma insulin concentrations.
Energy balance Change after 6 weeks (during week 6 of intervention versus baseline monitoring) Total energy expenditure minus total energy intake
Whole-body lipid utilisation during exercise Change throughout complete training period (weeks 1 through to 6). Samples will be collected during every training session (three times weekly for six weeks) Assessed via indirect calirometry during every exercise session (at ten minute intervals)
Fasting plasma glycerol concentrations Basal Concentrations - (change after 6 weeks) Fasting plasma glycerol concentrations (mmol/L)
Trial Locations
- Locations (1)
Department for Health, University of Bath
🇬🇧Bath, United Kingdom